PE20040722A1 - Formas cristalinas del acido 3-metiltiofen-2-carboxilico - Google Patents

Formas cristalinas del acido 3-metiltiofen-2-carboxilico

Info

Publication number
PE20040722A1
PE20040722A1 PE2003000741A PE2003000741A PE20040722A1 PE 20040722 A1 PE20040722 A1 PE 20040722A1 PE 2003000741 A PE2003000741 A PE 2003000741A PE 2003000741 A PE2003000741 A PE 2003000741A PE 20040722 A1 PE20040722 A1 PE 20040722A1
Authority
PE
Peru
Prior art keywords
methylthiophen
crystalline forms
carboxyl acid
refers
same
Prior art date
Application number
PE2003000741A
Other languages
English (en)
Spanish (es)
Inventor
Guido Jordine
Michael Mutz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20040722A1 publication Critical patent/PE20040722A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PE2003000741A 2002-07-29 2003-07-25 Formas cristalinas del acido 3-metiltiofen-2-carboxilico PE20040722A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0217504.0A GB0217504D0 (en) 2002-07-29 2002-07-29 Organic compounds

Publications (1)

Publication Number Publication Date
PE20040722A1 true PE20040722A1 (es) 2004-11-29

Family

ID=9941275

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000741A PE20040722A1 (es) 2002-07-29 2003-07-25 Formas cristalinas del acido 3-metiltiofen-2-carboxilico

Country Status (30)

Country Link
US (1) US7683048B2 (https=)
EP (2) EP1554303B1 (https=)
JP (1) JP2006501207A (https=)
KR (1) KR100688371B1 (https=)
CN (1) CN1305892C (https=)
AR (1) AR040692A1 (https=)
AT (1) ATE349459T1 (https=)
AU (1) AU2003251651B2 (https=)
BR (1) BR0313044A (https=)
CA (1) CA2493330C (https=)
CY (1) CY1106406T1 (https=)
DE (1) DE60310747T2 (https=)
DK (1) DK1554303T3 (https=)
EC (1) ECSP055579A (https=)
ES (1) ES2279970T3 (https=)
GB (1) GB0217504D0 (https=)
HK (1) HK1080484B (https=)
IL (2) IL166287A0 (https=)
MX (1) MXPA05001173A (https=)
MY (1) MY136407A (https=)
NO (1) NO20050806L (https=)
NZ (2) NZ549713A (https=)
PE (1) PE20040722A1 (https=)
PL (1) PL209409B1 (https=)
PT (1) PT1554303E (https=)
RU (2) RU2348646C1 (https=)
SI (1) SI1554303T1 (https=)
TW (1) TWI309164B (https=)
WO (1) WO2004013156A1 (https=)
ZA (1) ZA200500370B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
WO2002012266A1 (en) 2000-08-05 2002-02-14 Glaxo Group Limited 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
PT1383786E (pt) 2001-04-30 2008-12-30 Glaxo Group Ltd Derivados anti-inflamatórios de éster 17.beta-carbotioato de androstano com um grupo éster ciclíco na posição 17.alfa
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0523656D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0523654D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
GB0603783D0 (en) * 2006-02-24 2006-04-05 Novartis Ag Organic compounds
BRPI0909288A2 (pt) * 2008-03-14 2015-08-18 Otsuka Pharma Co Ltd Inibidores da mmp-2 e/ou da mmp-9

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU550939A1 (ru) * 1975-05-19 1994-07-15 Институт химии древесины АН ЛатвССР 1,2,3,4,4а,4в,5,6,10,10а -декагидро -6- хлорацетоксиметил -1,4а-диметил -7- (1-метилэтил) -1- фенантренкарбоновая кислота или ее соли
JPH08291073A (ja) * 1995-04-22 1996-11-05 Kissei Pharmaceut Co Ltd 医薬品組成物及びその製造方法
GB0015876D0 (en) * 2000-06-28 2000-08-23 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
RU2330043C2 (ru) 2008-07-27
CY1106406T1 (el) 2011-10-12
CN1671731A (zh) 2005-09-21
IL166287A0 (en) 2006-01-15
MXPA05001173A (es) 2005-05-16
AR040692A1 (es) 2005-04-13
DE60310747D1 (en) 2007-02-08
US20060166954A1 (en) 2006-07-27
JP2006501207A (ja) 2006-01-12
TWI309164B (en) 2009-05-01
SI1554303T1 (sl) 2007-06-30
ES2279970T3 (es) 2007-09-01
BR0313044A (pt) 2005-06-14
RU2005105688A (ru) 2005-10-10
US7683048B2 (en) 2010-03-23
ZA200500370B (en) 2006-07-26
PL209409B1 (pl) 2011-08-31
GB0217504D0 (en) 2002-09-04
CA2493330C (en) 2011-08-23
MY136407A (en) 2008-09-30
CN1305892C (zh) 2007-03-21
RU2348646C1 (ru) 2009-03-10
AU2003251651B2 (en) 2007-07-12
NZ549713A (en) 2008-04-30
HK1080484B (en) 2007-08-03
IL184848A0 (en) 2007-12-03
KR20050033632A (ko) 2005-04-12
NO20050806L (no) 2005-02-15
EP1676854A1 (en) 2006-07-05
ECSP055579A (es) 2005-04-18
ATE349459T1 (de) 2007-01-15
WO2004013156A1 (en) 2004-02-12
DE60310747T2 (de) 2007-10-11
HK1080484A1 (en) 2006-04-28
CA2493330A1 (en) 2004-02-12
EP1554303B1 (en) 2006-12-27
KR100688371B1 (ko) 2007-03-02
NZ537868A (en) 2006-11-30
RU2007143025A (ru) 2009-01-20
EP1554303A1 (en) 2005-07-20
PL373140A1 (en) 2005-08-22
TW200401633A (en) 2004-02-01
AU2003251651A1 (en) 2004-02-23
PT1554303E (pt) 2007-03-30
DK1554303T3 (da) 2007-04-30

Similar Documents

Publication Publication Date Title
PE20040722A1 (es) Formas cristalinas del acido 3-metiltiofen-2-carboxilico
EE200300171A (et) Kristalliline monohüdraat, meetodid selle valmistamiseks ja selle kasutamine farmatseutilise kompositsiooni valmistamiseks
DE69129248D1 (de) Peptide mit Endothelin antagonistischer Aktivität, deren Herstellung und pharmazeutische Zusammensetzungen
IT8619004A0 (it) Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
PE20020529A1 (es) Forma de dosificacion farmaceutica con multiples recubrimientos para reducir el impacto de fracturas del recubrimiento
EE200100010A (et) Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis
CA2514224A1 (en) Liquid pharmaceutical formulations of palonosetron
AU2003239609A1 (en) 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same
AU2003215245A1 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
EE200100007A (et) Kinoliini derivaadid, nende kasutamine ravimina, neid sisaldavad farmatseutilised kompositsioonid ning ühendite ja farmatseutiliste kompositsioonide kasutamine patoloogilisest põletikust ja autoimmuunsusest tingitud haiguste ravis
IT8848730A0 (it) Derivati 17beta-oh 19-nor steroidei sostituiti in 17alfa, procedimento di preparazione, loro impiego come medicamenti e composizioni farmaceutiche che li compongono
EE200100559A (et) Atsetüülsalitsüülhapet ja klopidogreelvesiniksulfaati sisaldav farmatseutiline kompositsioon üksikannusvormis
AU2003271510A1 (en) Formulation of oral compositions comprising arsenic trioxide and methods of use thereof
DE60022188D1 (de) Amorphe salpetersäureester und deren pharmazeutische zusammensetzungen
AU2003243719A1 (en) Topical administration of pharmacologically active bases in the treatment of warts
TR200400228T4 (tr) Psöryazinin tedavisinde kullanılacak maddeler
ATE534636T1 (de) Krystalline form ii von ritonavir enthaltende pharmazeutische zusammensetzung und ihre herstellung
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
PA8496701A1 (es) Polimorfos de un diclorhidrato cristalino de azobiciclo [2.2.2] oct- 3 - ilamina y sus composiciones farmaceuticas
AR033331A1 (es) Formas polimorfas de un citrato de azabiciclo [2,2,2] octan-3-amina, sus composiciones farmaceuticas, procedimiento de tratamiento y procedimiento para su produccion.
DK1590317T3 (da) Enantiomerren (4S,8S)- og (4R,8R)-4-p-nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1,11-undecandisyre og dennes derivater, fremgangsmåde til disses fremstilling og anvendelse til fremstilling af farmaceutiske midler
ATE196914T1 (de) Lh-rh analoge mit starrer konformation, deren verwendungen und pharmazeutische zusammensetzungen
IT1245371B (it) Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
SG134980A1 (en) Oral pharmaceutical compositions containing non-steroidal anti- inflammatory drugs and method for preparing the same
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция

Legal Events

Date Code Title Description
FC Refusal